Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

947 publication(s) found matching the search criteria

Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant


Author(s): Brachet C, Laemmle A, Cools M, Sauter K, De Baere E, Vanlander A, Pandey AV, du Toit T, Voegel CD, Heinrichs C, Verdin H, Flück CE
Affiliated Institution / ERN: Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; Ghent University Hospital ;
Condition / Disease: Chronic adrenocorticoid insufficiency
Publication: European Journal of Endocrinology v191.2 p144-155 Year: 2024 ORPHAcode / other: ORPHA101959
DOI: 10.1093/ejendo/lvae090 Keywords: TXNRD2,gonadal insufficiency,mitochondrial reactive oxygen species,primary adrenal insufficiency,steroidogenesis
MTG1

Patients with Thyroid Dyshormonogenesis and DUOX2 Variants: Molecular and Clinical Description and Genotype–Phenotype Correlation


Author(s): Baz-Redón N, Antolín M, Clemente M, Campos A, Mogas E, Fernández-Cancio M, Zafon E, García-Arumí E, Soler L, González-Llorens N, Aguilar-Riera C, Camats-Tarruella N, Yeste D
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Familial hyperthyroidism due to mutations in TSH receptor
Publication: International Journal of Molecular Sciences v25.15 p8473 Year: 2024 ORPHAcode / other: ORPHA424
DOI: 10.3390/ijms25158473 Keywords: CH,DUOX2,congenital hypothyroidism,dual oxidase 2,phenotypic variability,thyroid dyshormonogenesis
MTG8

18F‐fluoro‐ethyl‐tyrosine PET co‐registered with MRI in patients with persisting acromegaly


Author(s): Bakker LEH, Verstegen MJT, Manole DC, Lu H, Decramer TJM, Pelsma ICM, Kruit MC, Verbist BM, van de Ven A, Gurnell M, Ghariq I, van Furth WR, Biermasz NR, Pereira Arias‐Bouda LM
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ; Leiden University Medical Center ;
Condition / Disease: Prolactinoma
Publication: Clinical Endocrinology v101.2 p142-152 Year: 2024 ORPHAcode / other: ORPHA2965
DOI: 10.1111/cen.15079 Keywords: 18F‐fluoro‐ethyl‐tyrosine,acromegaly,functional imaging,multidisciplinary team,positron emission tomography,surgical decision making,transsphenoidal surgery
MTG6

Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis


Author(s): Mackay DJG, Gazdagh G, Monk D, Brioude F, Giabicani E, Krzyzewska IM, Kalish JM, Maas SM, Kagami M, Beygo J, Kahre T, Tenorio-Castano J, Ambrozaitytė L, Burnytė B, Cerrato F, Davies JH, Ferrero GB, Fjodorova O, Manero-Azua A, Pereda A, Russo S, Tannorella P, Temple KI, Õunap K, Riccio A, de Nanclares GP, Maher ER, Lapunzina P, Netchine I, Eggermann T, Bliek J, Tümer Z
Affiliated Institution / ERN: University Hospital Aachen ; Hôpital Bicêtre ;
Condition / Disease: Silver-Russell Syndrome
Publication: Clinical Epigenetics v16.1 Year: 2024 ORPHAcode / other: ORPHA813
DOI: 10.1186/s13148-024-01713-y Keywords: Clinical diagnosis,DMR,Differentially methylated regions,Imprinting disorder,MLID,Molecular diagnosis,Multi-locus imprinting disturbance
MTG5

High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma


Author(s): Frara S, Uygur MM, Bolamperti F, di Filippo L, Doga M, Ferrari F, Losa M, Mortini P, Giustina A
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Pituitary adenoma
Publication: Pituitary v27.4 p370-380 Year: 2024 ORPHAcode / other: ORPHA99408
DOI: 10.1007/s11102-024-01394-z Keywords: Hypogonadism,Hypopituitarism,Osteoporosis,Pituitary adenoma,Triiodothyronine,Vertebral fractures
MTG6

Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)


Author(s): Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF
Affiliated Institution / ERN: San Raffaele hospital - Milan ; Leiden University Medical Center ;
Condition / Disease: Acromegaly
Publication: Pituitary v27.4 p381-388 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1007/s11102-024-01397-w Keywords: Acromegaly,Cabergoline,Lanreotide,Octreotide,Pasireotide,Pegvisomant
MTG6

Towards the standardisation of adult person‐reported outcome domains in diabetes research: A Consensus Statement development panel


Author(s): Barnard‐Kelly K, Marrero D, de Wit M, Pouwer F, Khunti K, Hermans N, Pierce JS, Laffel L, Holt RIG, Battelino T, Naranjo D, Fosbury J, Fisher L, Polonsky W, Weissberg‐Benchell J, Hood KK, Schnell O, Messer LH, Danne T, Nimri R, Skovlund SE, Mader JK, Sherr JL, Schatz D, O'Neill S, Doble E, Town M, Lange K, de Beaufort C, Gonder‐Frederick L, Jaser SS, Liberman A, Klonoff D, ElSayed NA, Bannuru RR, Parkin CG, Snoek F
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ; Amsterdam UMC ; University Medical Centre Ljubljana ; Hannoversche Kinderheilanstalt ;
Condition / Disease: Diabetes mellitus
Publication: Diabetic Medicine v41.8 Year: 2024 ORPHAcode / other: ORPHA101952
DOI: 10.1111/dme.15332 Keywords: depression,distress,person‐reported outcomes,quality of life,treatment satisfaction,type 1 diabetes,type 2 diabetes
MTG3

The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study


Author(s): De Alcubierre D, Feola T, Cozzolino A, Pofi R, Galea N, Catalano C, Auriemma RS, Pirchio R, Pivonello R, Isidori AM, Giannetta E
Affiliated Institution / ERN: AOU Federico II - Naples ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Acromegaly
Publication: Pituitary v27.4 p416-427 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1007/s11102-024-01403-1 Keywords: Acromegaly,Cardiac magnetic resonance,Cardiomyopathy,Growth hormone,IGF1,Myocardial hypertrophy
MTG6

LINE1-mediated epigenetic repression of androgen receptor transcription causes androgen insensitivity syndrome


Author(s): Pozojevic J, Sivaprasad R, Laß J, Haarich F, Trinh J, Kakar N, Schulz K, Händler K, Verrijn Stuart AA, Giltay JC, van Gassen KL, Caliebe A, Holterhus P, Spielmann M, Hornig NC
Affiliated Institution / ERN: Universitätsklinikum Schleswig-Holstein ; University Medical Center Utrecht ;
Condition / Disease: Disorder of androgen action
Publication: Scientific Reports v14.1 Year: 2024 ORPHAcode / other: ORPHA754
DOI: 10.1038/s41598-024-65439-w Keywords:
MTG7

Healthcare professionals’ perspectives towards the digitalisation of paediatric growth hormone therapies: expert panels in Italy and Korea


Author(s): Rivera Romero O, Chae HW, Faienza MF, Vergani E, Cheon CK, Di Mase R, Frasca F, Lee HS, Giavoli C, Kim J, Klain A, Moon JE, Iezzi ML, Yeh J, Aversa A, Rhie Y, Koledova E
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; AOU Federico II - Naples ;
Condition / Disease: Combined pituitary hormone deficiencies, genetic forms
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ORPHA95494
DOI: 10.3389/fendo.2024.1419667 Keywords:
MTG6

Diagnostic work-up of ACTH-dependent Cushing’s syndrome in the context of CRH shortage: recommendation of a task force from the European Society of Endocrinology


Author(s): Colao A, Scaroni C, Mezösi E, Saiegh L, Puig-Domingo M, Marques P, Deutschbein T
Affiliated Institution / ERN: AOU Federico II - Naples ; Unidade Local de Saúde de Santa Maria(ULS de Santa Maria) ;
Condition / Disease: Cushing disease
Publication: European Journal of Endocrinology v191.1 pR32-R35 Year: 2024 ORPHAcode / other: ORPHA96253
DOI: 10.1093/ejendo/lvae073 Keywords:
MTG6

How nuclear imaging changed parathyroid surgical strategies through time


Author(s): Schouw HM, Noltes ME, Brouwers AH, Nilsson I, Zedenius J, Kruijff S
Affiliated Institution / ERN: University Medical Center Groningen ; Karolinska University Hospital ;
Condition / Disease: Follicular thyroid carcinoma
Publication: European Journal of Nuclear Medicine and Molecular Imaging v51.8 p2165-2171 Year: 2024 ORPHAcode / other: ORPHA146
DOI: https://doi.org/10.1007/s00259-024-06707-9 Keywords:
MTG8

Body Mass Index Distributions and Obesity Prevalence in a Transgender Youth Cohort – A Retrospective Analysis


Author(s): Knaus S, Steininger J, Klinger D, Riedl S
Affiliated Institution / ERN: Medical University of Vienna,Center for Disorders of Sex Development / Dpt. of Pediatrics ;
Condition / Disease: Transgender, female to male
Publication: Journal of Adolescent Health v75.1 p127-132 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1016/j.jadohealth.2024.03.005 Keywords: Adolescent,Auxology,Eating behaviours,Gender-affirming healthcare,Health behaviours,Obesity,Transgender
MTG7

Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety


Author(s): Malandrino P, Feola T, Mikovic N, Cannavale G, Molfetta SD, Altieri B, Mancini C, Ferolla P, Colao A, Faggiano A
Affiliated Institution / ERN: AOU Federico II - Naples ; University Hospital Würzburg ;
Condition / Disease: Multiple endocrine neoplasia type 1
Publication: Seminars in Nuclear Medicine v54.4 p570-580 Year: 2024 ORPHAcode / other: ORPHA652
DOI: 10.1053/j.semnuclmed.2024.05.001 Keywords:
MTG4

EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours


Author(s): Van Weehaeghe D, Lapauw B, Fraioli F, Cecchin D, Verger A, Guedj E, Albert NL, Brendel M, Yakushev I, Barthel H, Traub-Weidinger T, Tolboom N, Giessen EVD
Affiliated Institution / ERN: Ghent University Hospital ; Klinikum der Universität München ; University Medical Center Utrecht ; Amsterdam UMC ;
Condition / Disease: Pituitary adenoma
Publication: European Journal of Nuclear Medicine and Molecular Imaging v51.8 p2367-2370 Year: 2024 ORPHAcode / other: ORPHA99408
DOI: 10.1007/s00259-024-06728-4 Keywords:
MTG6

Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip), Pisa, Italy, 28–29 September 2023


Author(s): Ceccarini G, Akinci B, Araujo-Vilar D, Beghini M, Brown RJ, Carrion Tudela J, Corradin V, Donadille B, Jerez Ruiz J, Jeru I, Lattanzi G, Maffei M, McIlroy GD, Nobécourt E, Perez de Tudela N, Rochford JJ, Sanders R, von Schnurbein J, Tews D, Vantyghem M, Vatier C, Vigouroux C, Santini F
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; AOU Pisan ; Ulm University Medical Center ; AOU-Bologna ;
Condition / Disease: Familial partial lipodystrophy Type 1
Publication: Annales d'Endocrinologie v85.4 p308-316 Year: 2024 ORPHAcode / other: ORPHA98306
DOI: 10.1016/j.ando.2024.03.002 Keywords: Acanthosis nigricans,Adipogenesis,Caveolin,Gene therapy,Insulin resistance,Laminopathies,Leptin,Lipodystrophy syndromes,Metreleptin,NAFLD,PLAAT3,PPARγ,Perilipin,Registry,Seipin,Therapeutic education,VLDL1 secretion
MTG3

High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes


Author(s): Cremaschi A, Del Sindaco G, Pagnano A, Dolci A, Berkenou J, Rothenbuhler A, Contarino A, Ferrante E, Arosio M, Giannetta E, Linglart A, Mantovani G
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; Hôpital Bicêtre ;
Condition / Disease: Pseudohypoparathyroidism, all known genes excluded (iPPSDx)
Publication: The Journal of Clinical Endocrinology & Metabolism doi:10.1210/clinem/dgae416 Year: 2024 ORPHAcode / other: ORPHA97593
DOI: 10.1210/clinem/dgae416 Keywords: C-cell hyperplasia,calcitonin,hormonal resistance,pseudohypoparathyroidism
MTG2

Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF)


Author(s): Leboulleux S, Kapiteijn E, Litière S, Schöffski P, Godbert Y, Rodien P, Jarzab B, Salvatore D, Zanetta S, Capdevila J, Bastholt L, De La Fouchardiere C, Lalami Y, Bardet S, Cornélis F, Dedecjus M, Links T, Sents W, Schlumberger M, Locati DL, Newbold K
Affiliated Institution / ERN: University Medical Center Groningen ; Leiden University Medical Center ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ;
Condition / Disease: Follicular thyroid carcinoma
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ORPHA146
DOI: 10.3389/fendo.2024.1403687 Keywords: MTC,RAIR DTC,nintedanib,phase II trial,triple-angiokinase inhibitor
MTG8

Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche


Author(s): Cattoni A, Russo G, Capitoli G, Rodari G, Nicolosi ML, Molinari S, Tondelli D, Pelliccia C, Radaelli S, Arosio AML, Fontana K, Tattesi G, Passoni P, Boneschi A, Giavoli C, Meroni SLC, Stancampiano MR, Garuti E, Biondi A, Balduzzi A, Bizzarri C
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; San Raffaele hospital - Milan ;
Condition / Disease: Pituitary adenoma
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ORPHA99408
DOI: 10.3389/fendo.2024.1417281 Keywords: GnRH analogues,age of menarche,pelvic ultrasound,precocious puberty,uterine volume
MTG6 MTG7

Childhood craniopharyngioma: a retrospective study of children followed in Hôpital Universitaire de Bruxelles


Author(s): Magerman C, Boros E, Preziosi M, Lhoir S, Gilis N, De Witte O, Heinrichs C, Salmon I, Fricx C, Vermeulen F, Lebrun L, Brachet C, Rodesch M
Affiliated Institution / ERN: Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ;
Condition / Disease: Craniopharyngioma
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ORPHA54595
DOI: 10.3389/fendo.2024.1297132 Keywords: childhood craniopharyngioma,endocrine disorders,hypothalamic obesity,neurosurgery,radiotherapy,visual disorders
MTG6

Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study


Author(s): Menéndez-Torre EL, Gutiérrez-Hurtado A, Ollero MD, Irigaray A, Martín P, Parra P, González-Molero I, Araujo-Castro M, Idrobo C, Moure MD, Molina AR, Biagetti B, Iglesias P, Paja M, Villar-Taibo R, Pena A, Vicente A, Guerrero-Pérez F, Cordido F, Aulinas A, Mateu M, Soto A
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitari Vall d’Hebron ; Complejo Hospitalario Regional Virgen del Rocio ;
Condition / Disease: Non-functioning pituitary adenoma
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ORPHA91349
DOI: 10.3389/fendo.2024.1413810 Keywords: Rathke’s cleft cyst,cyst size,pituitary,transsphenoidal surgery,visual impairment
MTG6

Correction to: The diagnosis of hypophosphatasia in children as a multidisciplinary effort: an expert opinion


Author(s): Baroncelli GI, Carlucci G, Freri E, Giuca MR, Guarnieri V, Navarra G, Toschi B, Mora S
Affiliated Institution / ERN: San Raffaele hospital - Milan ; AOU Pisan ;
Condition / Disease: X-linked hypophosphataemia
Publication: Journal of Endocrinological Investigation v47.12 p3137-3137 Year: 2024 ORPHAcode / other: ORPHA89936
DOI: 10.1007/s40618-024-02403-5 Keywords:
MTG2

Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study


Author(s): Sampedro-Nuñez M, Herrera-Martínez AD, Ibáñez-Costa A, Rivero-Cortés E, Venegas E, Robledo M, Martínez-Hernández R, García-Martínez A, Gil J, Jordà M, López-Fernández J, Gavilán I, Maraver S, Marqués-Pamies M, Cámara R, Fajardo-Montañana C, Valassi E, Dios E, Aulinas A, Biagetti B, Álvarez Escola C, Araujo-Castro M, Blanco C, Paz dM, Villar-Taibo R, Álvarez CV, Gaztambide S, Webb SM, Castaño L, Bernabéu I, Picó A, Gálvez M, Soto-Moreno A, Puig-Domingo M, Castaño JP, Marazuela M, Luque RM, Adrados M, Flores PM, Leví AMR, Serrano-Somavilla A, Díez JJ, Villanueva MG, Iglesias P, Berrocal VR, Gutiérrez EA, Bances L, Calvo Gracia FL, Comunas F, López IQ, Hernando CA, Luis JMP, Centeno RG, Iza B, López CP, Zamarrón ÃP, Alén JF, Gutiérrez MC, Sansinenea IP, Otero Ã, Córdova JMR, Sousa P, Belinchón J, Herguido MJ, de Lope ÃR, Delgado AV, Muñoz F, Santos A, Asla Q, Servat AS, Torres A, Vidal N, Villabona C, Sesmilo G, Cambra GC, Obiols G, Carrato C, Salinas I, Hostalot C, Blanco A, Zabala R, Simón I, Ibáñez J, Fernández HG, Serra G, Riesgo P, Simal-Julian JA, Lamas C, Sandoval H, Abarca J, Mendoza NA, Ortiga RS, Monjas I, Font TP, Troncoso IA, Catalina PF, San Martín RMÃ, Ballesteros Pomar MD, Romero SP, Rodríguez EF, García-Allut A, Serramito R, Prieto A, Bellas LC, Pardo JIV, Expósito MRA, Moreno-Moreno P, Padillo-Cuenca JC, Vázquez-Borrego MC, Fuentes-Fayos AC, Leal-Cerro A, Japón MÃ, Rivera NG, Arnés JAG, González-Molero I, Maraver-Selfa S, Vela ET, Avilés-Pérez MD, Tenorio-Jiménez C, Carazo AM, García JGO
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitario Cruces ; Complejo Hospitalario Regional Virgen del Rocio ; Hospital Universitari Vall d’Hebron ;
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v190.6 p421-433 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1093/ejendo/lvae045 Keywords: REMAH study,combined molecular and clinical biomarkers,curation,pituitary tumor,transsphenoidal surgery
MTG6

Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion


Author(s): Biagetti B, Araujo-Castro M, Torre EM, Novoa-Testa I, Cordido F, Corrales EP, Berrocal VR, Guerrero-Pérez F, Vicente A, Percovich JC, Centeno RG, González L, García MDO, Echarri AI, Rodríguez MDM, Novo-Rodríguez C, Calatayud M, Villar-Taibo R, Bernabéu I, Alvarez-Escola C, Valderrama PB, Tenorio-Jiménez C, Galiana PA, Moreno EV, Molero IG, Iglesias P, Blanco C, De Lara FV, de Miguel P, Mezquita EL, Hanzu F, Aldecoa I, Aznar S, Lamas C, Aulinas A, Asla Roca Q, Gracia P, Córdova JMR, Aviles M, Asensio-Wandosel D, Sampedro M, Cámara R, Paja M, Ruz-Caracuel I, Fajardo-Montañana C, Asanza EC, Martinez-Saez E, Marazuela M, Puig-Domingo M
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitari Vall d’Hebron ; Complejo Hospitalario Regional Virgen del Rocio ;
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v190.6 p458-466 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1093/ejendo/lvae053 Keywords: acromegaly,cabergoline,dopamine agonist,first-line treatment,prolactin,somatostatin receptor ligand
MTG6

Clinical practice guidelines for the care of girls and women with Turner syndrome


Author(s): Gravholt CH, Andersen NH, Christin-Maitre S, Davis SM, Duijnhouwer A, Gawlik A, Maciel-Guerra AT, Gutmark-Little I, Fleischer K, Hong D, Klein KO, Prakash SK, Shankar RK, Sandberg DE, Sas TCJ, Skakkebæk A, Stochholm K, van der Velden JA, Alvarez-Nava F, Avdic HB, Balle CM, Bamba V, Bedei I, Bonnard Ã, Brickman WJ, Brown NM, Chernausek S, Cobbold J, Corathers SD, Corpechot C, Crenshaw ML, Davies M, Deeb A, Dessens A, Dowlut-McElroy T, Elliott V, Fadoju D, Fechner PY, Geffner M, Gitomer S, de Groote K, Hewitt J, Ho C, Hutaff-Lee C, Isojima T, Johannsen EB, Kawai M, Keselman A, Knickmeyer RC, Kremen J, Kristrøm B, Kruszka P, Law J, Lin AE, Loechner K, Mauras N, Matthews D, Mikkelborg T, Mortensen KH, Nahata L, Norman M, Patel SR, Quigley C, Ridder LO, Santen RJ, Sheanon N, Smyth A, Turner H, Verlinde F, Viuff MH, Wasniewska M, van der Weijde B, Woelfle J, Wolstencroft J, Backeljauw PF
Affiliated Institution / ERN: Aarhus University Hospital ; Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: 45,X
Publication: European Journal of Endocrinology v190.6 pG53-G151 Year: 2024 ORPHAcode / other: ORPHA881
DOI: 10.1093/ejendo/lvae050 Keywords: Turner syndrome,cardiovascular health,co-morbidity,hypogonadism,infertility,neurocognition,transition
MTG7

Molecular mechanisms of human overgrowth and use of omics in its diagnostics: chances and challenges


Author(s): Prawitt D, Eggermann T
Affiliated Institution / ERN: University Hospital Aachen ; University Medical Center Mainz ;
Condition / Disease: Beckwith-Wiedemann Syndrome
Publication: Frontiers in Genetics v15 Year: 2024 ORPHAcode / other: ORPHA116
DOI: 10.3389/fgene.2024.1382371 Keywords: diagnostics,long read sequencing,massive parallel sequencing (MPS),mosaicism,omics,overgrowth
MTG5

Primary Hypothyroidism in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review


Author(s): Milano MT, Vargo JA, Yorke ED, Ronckers CM, Kremer LC, Chafe SM, van Santen HM, Marks LB, Bentzen SM, Constine LS, Vogelius IR
Affiliated Institution / ERN: Amsterdam UMC ; University Medical Center Utrecht ; Copenhagen University Hospital, Rigshospitalet ;
Condition / Disease: Pediatric primary hypothyroidism
Publication: International Journal of Radiation Oncology*Biology*Physics v119.2 p482-493 Year: 2024 ORPHAcode / other:
DOI: 10.1016/j.ijrobp.2021.02.001 Keywords:
MTG8

A Novel De novo Heterozygous Mutation in the SON Gene Associated with Septo-optic Dysplasia: A New Phenotype


Author(s): Pasca L, Politano D, Cavallini A, Panzeri E, Vigone MC, Baldoli C, Abbate M, Kullmann G, Marelli S, Pozzobon G, Vincenzi G, Nacinovich R, Bassi MT, Romaniello R
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Septo-optic Dysplasia
Publication: Neuropediatrics v55.03 p191-195 Year: 2024 ORPHAcode / other: ORPHA3157; ORPHA46; ORPHA95488;
DOI: 10.1055/a-2114-4387 Keywords:
MTG6

Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism


Author(s): Vescini F, Borretta G, Chiodini I, Boniardi M, Carotti M, Castellano E, Cipriani C, Eller-Vainicher C, Giannini S, Iacobone M, Salcuni AS, Saponaro F, Spiezia S, Versari A, Zavatta G, Mitrova Z, Saulle R, Vecchi S, Antonini D, Basile M, Giovanazzi A, Paoletta A, Papini E, Persichetti A, Samperi I, Scoppola A, Novizio R, Calò PG, Cetani F, Cianferotti L, Corbetta S, De Rimini ML, Falchetti A, Iannetti G, Laureti S, Lombardi CP, Madeo B, Marcocci C, Mazzaferro S, Miele V, Minisola S, Palermo A, Pepe J, Scillitani A, Tonzar L, Grimaldi F, Cozzi R, Attanasio R
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; IRCCS Auxologico Italian Institute - Milan ; University Hospital of Padova ; AOU Pisan ; AOU-Bologna ; University Hospital Florence ; AOU Policlinico Umberto I - Rome ;
Condition / Disease: Hyperparathyroidism
Publication: Endocrine, Metabolic & Immune Disorders - Drug Targets v24.8 p991-1006 Year: 2024 ORPHAcode / other: ORPHA181408
DOI: 10.2174/0118715303260423231122111705 Keywords:
MTG2

Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management


Author(s): Grottoli S, Maffei P, Tresoldi AS, Granato S, Benedan L, Mariani P, Giustina A
Affiliated Institution / ERN: San Raffaele hospital - Milan ; AO City of Health and Science - Turin ;
Condition / Disease: Acromegaly
Publication: Journal of Endocrinological Investigation v47.12 p2999-3017 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1007/s40618-024-02386-3 Keywords: Acromegaly,Delphi,Pasireotide,Pegvisomant,Somatostatin receptor ligands (SRLs),Type 2 diabetes mellitus
MTG6
Page 4 of 32« First«...23456...102030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating HCP
Amsterdam UMC
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance